GABAergic responses to lithium chloride: dependence on dose, treatment length and experimental condition.
D000612:4-Aminobutyrate Transaminase / Q000378:metabolism*; D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects; D002712:Chlorides / Q000097:blood / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects; D004298:Dopamine / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D005968:Glutamate Decarboxylase / Q000378:metabolism*; D066298:In Vitro Techniques; D008094:Lithium / Q000097:blood / Q000494:pharmacology*; D018021:Lithium Chloride; D008297:Male; D009433:Neural Inhibition / Q000187:drug effects; D051381:Rats; D009435:Synaptic Transmission / Q000187:drug effects; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D002712:Chlorides; D005680:gamma-Aminobutyric Acid; D008094:Lithium; D000612:4-Aminobutyrate Transaminase; D005968:Glutamate Decarboxylase; D018021:Lithium Chloride; D004298:Dopamine